Liquim Ltd. announces the appointment of Adam James to the Liquim Board.

“Adam joins our board as a Non-Executive Director.  I know with his years of experience across research & technology commercialisation, he brings a wealth of knowledge to the Board.  We look forward to working with him“ – Sheryl Frame, Liquim’ s Chief Officer (CEO). Adam has over 15 years’ experience across research and technology commercialisation […]

Liquim. Ltd. announces the appointment of Grant Pestell to the Liquim Board.

“Having worked with Grant over many years in an informal capacity, having him join Liquim’s Board as Chair provides an opportunity to be working with him in a more formal capacity. I hope that together we can make great things happen“ – Sheryl Frame, Liquim’ s Chief Officer (CEO). Grant has over 25 years’ experience […]

Liquim Ltd announced restructure of management positions

In the two years and three months since Liquim’s inception, our biotechnology company has been making strong progress in its goal of providing solutions for a better world. This rapid growth has necessitated restructuring the organisation to ensure that we can take advantage of all opportunities. Effective today, I am pleased to announce that I […]

Ailene Thiel, International Collaboration and Commercialisation Expert joins the Liquim team

Liquim Pty. Ltd. announces the appointment of Ailene Thiel to our advisory team. “We are thrilled to have Ailene Thiel join our exciting journey, and look forward to working together on reducing risks to public health by bringing novel healthcare solutions to market” says Velimir Pajic, Liquim’s Chief Executive/Scientific Officer (CESO). Ailene Thiel is an […]

Sheryl Frame joins Liquim’s board

Liquim Pty. Ltd. Is pleased to announce that Sheryl Frame has been appointed as a Director to its Board. Sheryl continues to act in her role as the company’s Chief Business Development Officer (CBDO). “Sheryl has been a pivotal part in Liquim’s journey. We look forward to her continued contribution to the future success of […]

New Appointment

Liquim Pty Ltd announces the appointment of Dr Clay Golledge as Chief Medical Advisor. “We are happy to announce the appointment of Dr Golledge as a great addition to our Western Australian based medical biotechnology company”, says Sheryl Frame, Liquim’ s Chief Business Development Officer (CBDO). Clay is a well-known Physician in Infection Management and […]

Disclaimer

This website is designed to serve individuals interested in gathering information regarding Liquim Limited for investment or business purposes. The website includes details about products that may have varying availability or trademarks in different countries or for different purposes. If you are looking for information about Liquim products, we recommend you visit the dedicated product website in your country of residence. It's important to note that nothing presented on this website should be construed as solicitation, promotional material, or advertising for any product, including those in development. Furthermore, the information provided on this website is not intended to offer medical advice, and it should not be used as a substitute for guidance from a qualified healthcare professional or physician.